News

BOSTON June 28, 2024 — CILA Therapeutics CEO Safia Rizvi has been named to the prestigious 2024 50 Women to Watch for Corporate Boards list, by 50/50 Women on Boards. Rizvi is a visionary biopharmaceutical business executive and scientist, who has dedicated her career to discovering and commercializing treatments that improve people’s lives across the globe. Rizvi and the other finalists are recognized as board-ready executives, who can make an immediate positive impact.

BOSTON, April 10, 2023 — The Termeer Foundation is proud to announce the Class of 2023 Termeer Fellows. The Class of 2023 include Safia Rizvi, CILA Therapeutics; and 19 other outstanding entrepreneurs.

CILA Therapeutics was selected to present at the @MassBio Align Summit w/ insights by @McKinsey. The day will include keynotes, panel discussions, and pitches from other innovative seed/series A Biotech and MedTech start-ups.